Navigation Links
Berkery Noyes Releases 2011 Pharma & Healthcare Information and Technology Industry Mergers & Acquisitions Report
Date:1/19/2012

NEW YORK, Jan. 19, 2012 /PRNewswire/ -- Berkery Noyes, an independent middle market investment bank, today released its 2011 Full Year Mergers and Acquisitions trend report for the Pharma & Healthcare Information and Technology Industry.

The report analyzes the sector for 2011 and compares it with similar activity in 2009 and 2010. This market includes information and technology companies servicing pharmaceutical, healthcare payer, and healthcare provider companies.

Blackstone Group LP's acquisition of Emdeon, Inc. was the largest transaction for 2011, with an acquisition price of $3.03 billion. In terms of transaction type, 22% of industry deals were financed by private equity, venture capital, and other investment firms.

"In 2011, M&A-driven expansion of strategic healthcare technology and information platforms by major players, some private equity-backed, continued as a dominant trend," stated Jeffrey Smith, Managing Director in Berkery Noyes' Healthcare and Life Sciences group. "This trend will continue in 2012, offering an active market, competitive sales processes, and excellent valuation opportunities for independently-owned companies providing software, information, data, communications and services solutions to the healthcare and life science industries."

Median revenue and EBITDA multiples fell from 2010 to 2011. The median revenue multiple decreased from 2.0x to 1.6x, while the median EBITDA multiple went from 11.6x to 9.0x. Although total transaction value declined 9 percent over the last twelve months, total transaction volume increased 15 percent, from 255 to 292 this year.

Based on value, the most active market segment that Berkery Noyes tracked between 2009 and 2011 was Healthcare IT with $10.25 billion worth of transactions.

"The healthcare information and technology ("HIT") mergers and acquisitions market was robust in 2011 as buyers looked to acquire rapidly growing companies, principally software enabled solutions (SaaS and Cloud enabled), in highly attractive niches to accelerate their own growth and offer fuller suites of world class products to the dynamic and growing healthcare marketplace," said Tom O'Connor, Managing Director in Berkery Noyes' Healthcare and Life Sciences group. "In 2012, we expect to see an increased deal flow and attractive prices for sellers from both strategic and financial buyers, but strategic buyers, like in 2011, will dominate the buyer universe."

According to Jonathan Krieger, Managing Director in Berkery Noyes' Healthcare and Life Sciences group, "The number of HIT transactions increased for the 3rd consecutive year and valuation multiples continued to rise. The enactment of the HITECH Act has catalyzed the adoption of IT by both payors and providers and has resulted in a very favorable M&A market for private companies that wish to pursue liquidity events."

Berkery Noyes specializes in structuring debt and equity transactions in the $25 million to $500 million range, a market that is enjoying a surge in activity. Unique among investment banking firms, Berkery Noyes combines independent strategic research and industry intelligence with senior information technology banking expertise. Long having been an innovator in database and research technology in M&A, Berkery Noyes has committed itself to providing more expansive and current information. The firm's research teams publish acquisition activity in the respective sectors they follow on MandAsoft.com.

A copy of the FULL YEAR 2011 PHARMA & HEALTHCARE INFORMATION AND TECHNOLOGY INDUSTRY M&A TREND REPORT is available at the Berkery Noyes website.

About Berkery Noyes

Berkery Noyes is an independent investment banking advisory firm servicing the information industry. Focused on middle-market corporations and financial sponsors, Berkery Noyes is committed to delivering a comprehensive array of industry-leading advisory services. Since its founding by Joseph W. Berkery in 1983, the firm has worked with corporate clients to grow through acquisition, divest non-core assets, and maximize shareholder returns through strategic transactions and restructurings. For private owners, Berkery Noyes helps create liquidity and execute timely exit strategies that achieve their personal and professional objectives. For more information, visit www.berkerynoyes.com.

Contact Information:
Peter Wilson
Berkery Noyes
646-442-7966
peter.wilson@berkerynoyes.com

 

 

 


'/>"/>
SOURCE Berkery Noyes
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
2. Berkery Noyes Releases 2009 Pharma and Healthcare Information Merger & Acquisition Trends
3. Berkery Noyes Releases First Half 2011 M&A Report for the Pharma and Healthcare Information and Technology Industry
4. Berkery Noyes Releases Third Quarter 2011 Mergers & Acquisitions Update for the Pharma and Healthcare Information and Technology Industry
5. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
6. CEL-SCI Corporation Releases Letter to Shareholders
7. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
8. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
9. Immunosyn Corporation Releases SF-1019 Study Results
10. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
11. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 12, 2016  Sequent Medical, Inc. announced today that ... evaluate the safety and effectiveness of the WEB™ Aneurysm ... intracranial aneurysms.  Prof Laurent Spelle , MD, Head ... Paris, France and Principal Investigator of the ... France and Germany.  Although patients with ruptured ...
(Date:2/12/2016)... 2016  OMS Supply, a large provider of oral ... today the recent launching of their new company website. ... features that enhance the user experience and enable practitioners ... --> --> Despite the ... that started in early 2016, they have already made ...
(Date:2/11/2016)... Feb. 11, 2016 - ... in Personalized Medicine and Cancer Therapy. - European ... Diagnostic Testing Markets. - Key Diagnostic Testing Markets. ... Molecular Diagnostics in Genetic Testing. - Molecular Diagnostics ... - Over-the-Counter Diagnostic Products World Markets. - ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... , ... When an Au Pair comes all the way around the world to ... and they are often worried things won’t go well. More often than not, however, they ... Pair of the Year winner’s all commented how their Au Pairs have become a part ...
(Date:2/12/2016)... Los Angeles, CA (PRWEB) , ... February 12, 2016 , ... ... da Vinci-assisted hernia surgeries are beginning to account for a significant portion of hernia ... Dr. Shirin Towfigh of the Beverly Hills Hernia Center notes that this trend has ...
(Date:2/12/2016)... (PRWEB) , ... February 12, ... ... Foundation today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the ... partnership will recruit top students from U.S. universities who will draw from ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... life cycle of pharmaceutical products, garnering increased attention from all stakeholders in the ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of coconut water ... LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities the company’s ... big event. The invitation-only gifting suite, held this year at the W Hollywood Hotel, ...
Breaking Medicine News(10 mins):